Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 267: Leading Legal Strategy at a Growing Health System with Kelli Ferry of Novant Health
We get AI for work™: Preparing Real-World Healthcare Environments for an AI-Driven Future
Health-e Law Podcast, Episode 20 | J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A
Podcast - Minority Deals in Healthcare Private Equity: An Evolving Opportunity for GPs and Founders Counsel That Cares Podcast Series
Pay Transparency + the Power of Preventive Strategies: Episode 3 — Pivoting Toward Preparation in the Life Sciences
Pay Transparency + the Power of Preventive Strategies: Episode 2 — Healthcare Compliance Crossroads
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 266: Navigating Today’s Healthcare Landscape with Leighton Roper of Maynard Nexsen
Hospice Insights Podcast - Reimagining How We Navigate Change and Loss: A Conversation with Sonya Dolan and Bridget Sumser of Mettle Health
Podcast - The Fast-Growing Wound Care Industry
Concierge Practices: Getting Started and Staying Compliant
Podcast - J.P. Morgan Healthcare Conference Recap: What Dealmakers Expect in 2026
Illinois Supreme Court Tightens Standing for No-Injury Consumer Claims — The Consumer Finance Podcast
Work This Way: A Labor & Employment Law Podcast | Service Animals, the ADA, and Workplace Rights
Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare
From Diligence to Post-Closing: What’s Shifting in 2026 Health Care Transactions
Private Equity Investment in Health Care
Healthcare Trend Report: A Review of the Pharmacy and Drug Supply Chain Sectors
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — Payments Pros – The Payments Law Podcast
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — The Consumer Finance Podcast
AGG Talks: Government Insight for Life Sciences Leaders | Patient Assistance Programs and the False Claims Act: Enforcement Trends and Compliance Risks for Life Sciences Companies
News Briefs - Trump Signs Funding Package Including Key Healthcare Provisions - President Trump signed into law a funding bill that ended a short-term partial government shutdown, funds the Department of Health and Human...more
On January 20, 2026, the New Jersey Governor signed Assembly Bill A5017 (“Amendment”), amending the New Jersey Data Protection Act (“NJDPA”). The Amendment exempts data that is not protected health information (“non-PHI”)...more
Hyperscalers increasingly sit behind core healthcare delivery and life‑sciences innovation. Cloud storage and compute now support electronic health records (EHRs), telehealth platforms, imaging archives, clinical trial...more
Telehealth weight-loss platforms offering rapid GLP-1 prescriptions have become one of the fastest-growing segments in healthcare. These platforms connect consumers with clinicians via virtual consultations to assess...more
Bass, Berry & Sims is pleased to bring you our 14th annual Healthcare Fraud & Abuse Review in which we cover significant civil and criminal enforcement issues for healthcare providers....more
On February 3, 2026, the Consolidated Appropriations Act, 2026 (P.L. 119-75) became law and marked an important milestone in the bipartisan congressional effort to reauthorize the rare pediatric disease priority review...more
In case you missed it, Department of Health and Human Services Secretary Robert F. Kennedy Jr. and former Food and Drug Administration (FDA) Commissioner David Kessler appeared on 60 Minutes this past Saturday, February 15,...more
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on extending the recognition of EU CE marked devices in Great Britain indefinitely. The consultation seeks feedback on proposals that...more
Over the last two years, the Office of Inspector General for the Department of Health and Human Services (“OIG”) has conducted a series of audits focusing on State and nursing home compliance with Federal and State...more
If, like many commentators, you expected a post-2024 shift away from traditional financial-crimes enforcement and toward emerging areas such as cybercrime, antitrust or consumer protection, that expectation has not...more
The Centers for Medicare & Medicaid Services (CMS) are required to update and publish payment policies and rates for hospital outpatient departments and ambulatory surgery centers (ASCs) annually. In November 2025, CMS...more
Welcome to our second issue of 2026 of The Health Record -- our healthcare law insights e-newsletter. In this edition, we look at recent guidance from HHS urging healthcare providers to step up cybersecurity efforts,...more
In this episode, we welcome back Kelli Ferry, recently promoted to Chief Legal Officer and Executive Vice President of Novant Health. Kelli shares how her role has evolved as Novant expands across the Southeast, offering...more
Does your practice offer MRI, PET or CT imaging to Medicare patients? If so, you may not be following the requirements of the Physician Self-Referral Law (commonly referred to as the “Stark” law). The Stark law regulates...more
To help HIPAA covered entities comply with updated rules for substance use disorder patient records, the U.S. Department of Health and Human Services Office of Civil Rights has published updated language for Notices of...more
On February 5, the Food and Drug Administration (FDA) announced a major change in how the agency will regulate claims about artificial colors in foods. In a “Letter to the Food Industry,” the FDA declared that the agency...more
On February 2, 2026, CMS issued updated guidance on Medicaid state directed payment (“SDPs”) governed by Section 71116 of the “Working Families Tax Cuts Legislation” enacted in the One Big Beautiful Bill Act (“OBBBA”). The...more
The Food and Drug Administration (FDA) has issued a Refuse-to-File (RTF) letter to Moderna, Inc. regarding its Biologics License Application (BLA) for the investigational mRNA-based influenza vaccine “mRNA-1010.” Moderna...more
Last November, we informed you of the new occupational health and safety obligations arising from the Regulation respecting prevention and participation mechanisms in establishments (the "Regulation"), which came into force...more
This is the sixth post in the Dorsey FCANow Blog’s FCA Basics Series covering the fundamentals of the False Claims Act (“FCA”), outlining FCA procedure, and highlighting key facets of FCA practice. Today’s post discusses a...more
In 2025, eight new U.S. state privacy laws took effect and several states tightened existing regulations, significantly impacting healthcare organizations. Major changes include strengthened opt-out rights, new protections...more
A disaster declaration related to the New World screwworm, an agency's adjusted approach to "no artificial colors" claims, Florida's investigation into pesticides in bread, and more....more
The US Food and Drug Administration (FDA) recently announced that brands may label their products as without “artificial colors” as long as the colors are not petroleum-based. Although this may provide limited comfort from an...more
The 10th Anniversary of the False Claims Act Guide 2026 – Year in review and looking ahead comes at a pivotal moment for False Claims Act (FCA) enforcement. The past year brought significant enforcement momentum alongside...more
Workplace violence continues to be a growing challenge affecting healthcare workers. To support workers and avoid fines and other enforcement actions, employers in the healthcare industry may wish to analyze risk factors and...more
